Carmen Mignogna

565 total citations
18 papers, 213 citations indexed

About

Carmen Mignogna is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Carmen Mignogna has authored 18 papers receiving a total of 213 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Genetics and 5 papers in Surgery. Recurrent topics in Carmen Mignogna's work include Diabetes and associated disorders (8 papers), Diabetes Management and Research (7 papers) and Diabetes Treatment and Management (5 papers). Carmen Mignogna is often cited by papers focused on Diabetes and associated disorders (8 papers), Diabetes Management and Research (7 papers) and Diabetes Treatment and Management (5 papers). Carmen Mignogna collaborates with scholars based in Italy, United Kingdom and Spain. Carmen Mignogna's co-authors include Raffaella Buzzetti, Ernesto Maddaloni, Luca D’Onofrio, Chiara Moretti, Gaetano Leto, Frida Leonetti, Silvia Pieralice, Silvia Manfrini, Flavia Agata Cimini and Angela Carlone and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes and International Journal of Molecular Sciences.

In The Last Decade

Carmen Mignogna

18 papers receiving 212 citations

Peers

Carmen Mignogna

EDM

GENET

EPIDE

SURGE

Adeel Ahmad Khan Qatar

İbrahim Demirci Türkiye

Nihat Buğra Ağaoğlu Türkiye

Aakash Desai United States

Vasiliki Vasileiou Greece

Kazuna Takata Japan

Redha Attaoua France

Lauren M. Quinn United Kingdom

Sukrita Bhattacharjee India

Elisabetta Lovati Italy

Adeel Ahmad Khan Qatar

Carmen Mignogna

89 ×0.9

EDM

47 ×0.6

GENET

55 ×0.8

39 ×0.7

EPIDE

71 ×1.6

SURGE

Citations per year, relative to Carmen Mignogna Carmen Mignogna (= 1×) peers Adeel Ahmad Khan

Countries citing papers authored by Carmen Mignogna

Since Specialization

Citations

This map shows the geographic impact of Carmen Mignogna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Mignogna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Mignogna more than expected).

Fields of papers citing papers by Carmen Mignogna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Mignogna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Mignogna. The network helps show where Carmen Mignogna may publish in the future.

Co-authorship network of co-authors of Carmen Mignogna

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Mignogna. A scholar is included among the top collaborators of Carmen Mignogna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Mignogna. Carmen Mignogna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

D’Onofrio, Luca, Stefano Di Giulio, Carmen Mignogna, et al.. (2025). IFN-α Neutralizing Antibodies Distinguish LADA From Early-onset Type 1 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 110(9). 2565–2572. 1 indexed citations

Maddaloni, Ernesto, Anda Mihaela Naciu, Carmen Mignogna, et al.. (2024). Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study. Diabetes Obesity and Metabolism. 26(5). 1670–1677. 3 indexed citations

D’Onofrio, Luca, et al.. (2024). No Differences in Kidney Function Decline Between People With Type 2 Diabetes Starting a Sodium-Glucose Cotransporter 2 Inhibitor or a Glucagon-like Peptide-1 Receptor Agonist: A Real-world Retrospective Comparative Observational Study. Clinical Therapeutics. 46(11). 828–834. 2 indexed citations

Csermely, Alessandro, Alessandro Mantovani, Mario Luca Morieri, et al.. (2023). Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus. Diabetes & Metabolism. 49(6). 101477–101477. 5 indexed citations

Mantovani, Alessandro, Mario Luca Morieri, Raffaella Aldigeri, et al.. (2023). MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus. Diabetes & Metabolism. 50(1). 101497–101497. 23 indexed citations

D’Onofrio, Luca, Carmen Mignogna, Gaetano Leto, et al.. (2023). Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications. International Journal of Molecular Sciences. 24(21). 15809–15809. 2 indexed citations

Mantovani, Alessandro, Mario Luca Morieri, Maria Masulli, et al.. (2023). Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus. Cardiovascular Diabetology. 22(1). 204–204. 15 indexed citations

Dei, Alessandra, Raffaella Aldigeri, Alessandro Mantovani, et al.. (2023). Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 108(9). e789–e798. 9 indexed citations

D’Onofrio, Luca, Marta Fogolari, Carmen Mignogna, et al.. (2022). Reduced early response to SARS‐CoV2 vaccination in people with type 1 and type 2 diabetes, a 6 months follow‐up study: The CoVaDiab study I. Diabetes/Metabolism Research and Reviews. 39(3). 5 indexed citations

10.

Leto, Gaetano, Lida Tartaglione, Silverio Rotondi, et al.. (2022). Diastolic Pressure and ACR Are Modifiable Risk Factors of Arterial Stiffness in T2DM Without Cardiovascular Disease. The Journal of Clinical Endocrinology & Metabolism. 107(9). e3857–e3865. 3 indexed citations

11.

Maddaloni, Ernesto, Luca D’Onofrio, Carmen Mignogna, et al.. (2021). Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19: a systematic review and meta-analysis. Internal and Emergency Medicine. 16(7). 1975–1985. 6 indexed citations

12.

D’Onofrio, Luca, Carmen Mignogna, Angela Carlone, et al.. (2021). Decrease of coronary heart disease risk with GLP1-receptor agonists or SGLT2 inhibitors therapy in patients with type 2 diabetes in primary cardiovascular prevention: A 24 months follow-up study. Diabetes Research and Clinical Practice. 173. 108681–108681. 11 indexed citations

13.

D’Onofrio, Luca, Angela Carlone, Carmen Mignogna, et al.. (2021). Short-term safety profile of Sars-Cov2 vaccination on glucose control: Continuous glucose monitoring data in people with autoimmune diabetes. Diabetes Research and Clinical Practice. 179. 109022–109022. 13 indexed citations

14.

D’Onofrio, Luca, Silvia Pieralice, Ernesto Maddaloni, et al.. (2021). Effects of the COVID ‐19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study. Diabetes Obesity and Metabolism. 23(7). 1624–1630. 45 indexed citations

15.

Mignogna, Carmen, Ernesto Maddaloni, Luca D’Onofrio, & Raffaella Buzzetti. (2021). Investigational therapies targeting CD3 for prevention and treatment of type 1 diabetes. Expert Opinion on Investigational Drugs. 30(12). 1209–1219. 19 indexed citations

16.

Maddaloni, Ernesto, Chiara Moretti, Carmen Mignogna, & Raffaella Buzzetti. (2020). Adult-onset autoimmune diabetes in 2020: An update. Maturitas. 137. 37–44. 23 indexed citations

17.

Maddaloni, Ernesto, Luca D’Onofrio, Francesco Alessandri, et al.. (2020). Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I). Diabetes Research and Clinical Practice. 169. 108454–108454. 27 indexed citations

18.

Pieralice, Silvia, Ernesto Maddaloni, Anna Rita Maurizi, et al.. (2020). 1217-P: Improvement of Metabolic Control in Type 1 Diabetes after Transition Is Independent from Referral Center and Insulin Regimen. Diabetes. 69(Supplement_1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact